Clinical trial
A Study of the Therapeutic Equivalency of MF DPI 100 mcg and 200 mcg Inhalers in Corticosteroid-Dependent Subjects With Moderate Asthma
NCT00521599 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of the Therapeutic Equivalency of MF DPI 100 mcg and 200 mcg Inhalers in Corticosteroid-Dependent Subjects With Moderate Asthma
- Lead sponsor
- Organon and Co
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2007
- Completion date
- March 31, 2009
- Enrollment
- 672 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.